Literature DB >> 24149933

Blood glutamate scavenging as a novel neuroprotective treatment for paraoxon intoxication.

Angela Ruban1, Boaz Mohar1, Ghil Jona2, Vivian I Teichberg1.   

Abstract

Organophosphate-induced brain damage is an irreversible neuronal injury, likely because there is no pharmacological treatment to prevent or block secondary damage processes. The presence of free glutamate (Glu) in the brain has a substantial role in the propagation and maintenance of organophosphate-induced seizures, thus contributing to the secondary brain damage. This report describes for the first time the ability of blood glutamate scavengers (BGS) oxaloacetic acid in combination with glutamate oxaloacetate transaminase to reduce the neuronal damage in an animal model of paraoxon (PO) intoxication. Our method causes a rapid decrease of blood Glu levels and creates a gradient that leads to the efflux of the excess brain Glu into the blood, thus reducing neurotoxicity. We demonstrated that BGS treatment significantly prevented the peripheral benzodiazepine receptor (PBR) density elevation, after PO exposure. Furthermore, we showed that BGS was able to rescue neurons in the piriform cortex of the treated rats. In conclusion, these results suggest that treatment with BGS has a neuroprotective effect in the PO intoxication. This is the first time that this approach is used in PO intoxication and it may be of high clinical significance for the future treatment of the secondary neurologic damage post organophosphates exposure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24149933      PMCID: PMC3915200          DOI: 10.1038/jcbfm.2013.186

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  36 in total

1.  Anticonvulsant actions of anticholinergic drugs in soman poisoning.

Authors:  B R Capacio; T M Shih
Journal:  Epilepsia       Date:  1991 Sep-Oct       Impact factor: 5.864

2.  The neuroprotective effects of oxaloacetate in closed head injury in rats is mediated by its blood glutamate scavenging activity: evidence from the use of maleate.

Authors:  Alexander Zlotnik; Shaun E Gruenbaum; Alan A Artru; Irene Rozet; Michael Dubilet; Sergey Tkachov; Evgeny Brotfain; Yael Klin; Yoram Shapira; Vivian I Teichberg
Journal:  J Neurosurg Anesthesiol       Date:  2009-07       Impact factor: 3.956

3.  Fluorometric determination of aspartate, glutamate, and gamma-aminobutyrate in nerve tissue using enzymic methods.

Authors:  L T Graham; M H Aprison
Journal:  Anal Biochem       Date:  1966-06       Impact factor: 3.365

4.  A rapid and simple procedure for chronic cannulation of the rat jugular vein.

Authors:  P G Harms; S R Ojeda
Journal:  J Appl Physiol       Date:  1974-03       Impact factor: 3.531

5.  Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats.

Authors:  E Gilat; T Kadar; A Levy; I Rabinovitz; G Cohen; Y Kapon; R Sahar; R Brandeis
Journal:  Toxicol Appl Pharmacol       Date:  2005-11-15       Impact factor: 4.219

6.  Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells.

Authors:  Katayun Cohen-Kashi-Malina; Itzik Cooper; Vivian I Teichberg
Journal:  J Cereb Blood Flow Metab       Date:  2011-09-14       Impact factor: 6.200

7.  Development of a prolonged calcium plateau in hippocampal neurons in rats surviving status epilepticus induced by the organophosphate diisopropylfluorophosphate.

Authors:  Laxmikant S Deshpande; Dawn S Carter; Robert E Blair; Robert J DeLorenzo
Journal:  Toxicol Sci       Date:  2010-05-23       Impact factor: 4.849

8.  Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs.

Authors:  J H McDonough; L D Zoeffel; J McMonagle; T L Copeland; C D Smith; T M Shih
Journal:  Epilepsy Res       Date:  2000-01       Impact factor: 3.045

Review 9.  Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies.

Authors:  V I Teichberg; K Cohen-Kashi-Malina; I Cooper; A Zlotnik
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

10.  Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors.

Authors:  Máriton D Santos; Edna F R Pereira; Yasco Aracava; Newton G Castro; William P Fawcett; William R Randall; Edson X Albuquerque
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

View more
  8 in total

1.  Characterization of the L-glutamate clearance pathways across the blood-brain barrier and the effect of astrocytes in an in vitro blood-brain barrier model.

Authors:  Hans Cc Helms; Blanca I Aldana; Simon Groth; Morten M Jensen; Helle S Waagepetersen; Carsten U Nielsen; Birger Brodin
Journal:  J Cereb Blood Flow Metab       Date:  2017-02-01       Impact factor: 6.200

Review 2.  Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection.

Authors:  Ming Jia; Steve A Noutong Njapo; Vaibhav Rastogi; Vishnumurthy Shushrutha Hedna
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

Review 3.  Is there a role for glutamate-mediated excitotoxicity in inflammation-induced depression?

Authors:  Robert Dantzer; Adam K Walker
Journal:  J Neural Transm (Vienna)       Date:  2014-03-15       Impact factor: 3.575

Review 4.  Extracorporeal methods of blood glutamate scavenging: a novel therapeutic modality.

Authors:  Agzam Zhumadilov; Matthew Boyko; Shaun E Gruenbaum; Evgeny Brotfain; Federico Bilotta; Alexander Zlotnik
Journal:  Expert Rev Neurother       Date:  2015-04-12       Impact factor: 4.618

Review 5.  Glutamate, T cells and multiple sclerosis.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2017-02-24       Impact factor: 3.575

Review 6.  Brain to blood glutamate scavenging as a novel therapeutic modality: a review.

Authors:  Matthew Boyko; Shaun E Gruenbaum; Benjamin F Gruenbaum; Yoram Shapira; Alexander Zlotnik
Journal:  J Neural Transm (Vienna)       Date:  2014-03-13       Impact factor: 3.575

7.  MRS of brain metabolite levels demonstrates the ability of scavenging of excess brain glutamate to protect against nerve agent induced seizures.

Authors:  Angela Ruban; Inbal E Biton; Arik Markovich; David Mirelman
Journal:  Int J Mol Sci       Date:  2015-02-02       Impact factor: 5.923

8.  Elevated baseline serum glutamate as a pharmacometabolomic biomarker for acamprosate treatment outcome in alcohol-dependent subjects.

Authors:  H W Nam; V M Karpyak; D J Hinton; J R Geske; A M C Ho; M L Prieto; J M Biernacka; M A Frye; R M Weinshilboum; D-S Choi
Journal:  Transl Psychiatry       Date:  2015-08-18       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.